AllergoOncology: the role of IgE‐mediated allergy in cancer
Open Access
- 8 September 2008
- Vol. 63 (10), 1255-1266
- https://doi.org/10.1111/j.1398-9995.2008.01768.x
Abstract
Epidemiological studies have suggested inverse associations between allergic diseases and malignancies. As a proof of concept for the capability of immunoglobulin E (IgE) to destruct tumor cells, several experimental strategies have evolved to specifically target this antibody class towards relevant tumor antigens. It could be demonstrated that IgE antibodies specific to overexpressed tumor antigens have been superior to any other immunoglobulin class with respect to antibody‐dependent cellular cytotoxicity (ADCC) and phagocytosis (ADCP) reactions. In an alternative approach, IgE nonspecifically attached to tumor cells proved to be a powerful adjuvant establishing tumor‐specific immune memory. Active Th2 immunity could also be achieved by applying an oral immunization regimen using mimotopes, i.e. epitope mimics of tumor antigens. The induced IgE antibodies could be cross‐linked by live tumor cells leading to tumoricidic mediator release. Thus, IgE antibodies may not only act in natural tumor surveillance, but could possibly also be exploited for tumor control in active and passive immunotherapy settings. Thereby, eosinophils, mast cells and macrophages can be armed with the cytophilic IgE and become potent anti‐tumor effectors, able to trace viable tumor cells in the tissues. It is strongly suggested that the evolving new field AllergoOncology will give new insights into the role of IgE‐mediated allergy in malignancies, possibly opening new avenues for tumor therapy.Keywords
This publication has 136 references indexed in Scilit:
- Polyclonal Immunoglobulin E Levels Are Correlated with Hemoglobin Values and Overall Survival in Patients with Multiple MyelomaClinical Cancer Research, 2007
- Breast cancer instructs dendritic cells to prime interleukin 13–secreting CD4+ T cells that facilitate tumor developmentThe Journal of Experimental Medicine, 2007
- Pivotal Advance: Eosinophil infiltration of solid tumors is an early and persistent inflammatory host responseJournal of Leukocyte Biology, 2006
- Le polynucléaire éosinophile: Structure et fonctionsLa Presse Médicale, 2006
- On the Prediction of the Human Response: A Recycled Mechanistic Pharmacokinetic/Pharmacodynamic ApproachBasic & Clinical Pharmacology & Toxicology, 2005
- In situ eosinophil activation in 26 primary cutaneous T-cell lymphomas with blood eosinophiliaJournal of the American Academy of Dermatology, 2005
- IgY: clues to the origins of modern antibodiesImmunology Today, 1995
- Growth inhibition of murine mammary carcinoma by monoclonal IgE antibodies specific for the mammary tumor virusCancer Immunology, Immunotherapy, 1991
- Physicochemical properties of reaginic antibodyJournal of Allergy, 1966
- The distribution of reagins in the blood plasmaJournal of Allergy, 1931